Sagimet Biosciences
Latest round
- Series F
Last raised
- Dec 2020
Total raised
- $169M
Investors
- 11
About Sagimet Biosciences
Based in California, US, and founded in 2006, Sagimet Biosciences Inc. is a clinical-stage pharmaceutical company that develops novel therapeutics for the treatment of oncology like breast cancer, astrocytoma, colon cancer, and other infectious diseases such as non-alcoholic steatohepatitis (NASH). The company was founded by Lucas Pelkmans and Urs Greber. In February 2021, Sagimet Biosciences Inc. The company offers TVB-2640, which targets and synthesizes fatty acid synthase (FASN). It also offers antiviral therapeutics for the respiratory syncytial virus (RSV), cytomegalovirus (CMV), and other human pathogens. Sagimet Biosciences plans to advance its lead program, explore additional indications, and file an IND on a second FASN inhibitor, TVB-3567, by the end of 2021.
Who invested in Sagimet Biosciences
11 investors across 8 rounds
See all investors in Sagimet Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series F
Dec 21, 2020
Amount
$69M
Investors
Series E
Feb 12, 2019
Amount
$35M
Investors
Series D
Oct 22, 2014
Amount
$14M
Investors
Series C
Jun 14, 2013
Amount
$7.5M
Investors
Series B
Dec 19, 2012
Amount
$8.1M
Investors
Series B
Nov 29, 2011
Amount
$12M
Investors
Series B
Jul 7, 2009
Amount
$15M
Investors
Series A
Apr 30, 2007
Amount
$7.6M
Investors
Questions about Sagimet Biosciences
Who invested in Sagimet Biosciences?
Sagimet Biosciences has 11 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sagimet Biosciences raised?
Sagimet Biosciences has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did Sagimet Biosciences last raise money?
Sagimet Biosciences's most recent round on record is a Series F, in Dec 2020.
What does Sagimet Biosciences do?
Based in California, US, and founded in 2006, Sagimet Biosciences Inc.
Where is Sagimet Biosciences headquartered?
Sagimet Biosciences is headquartered in San Mateo, US.
Which VCs invest in companies like Sagimet Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sagimet Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series F
Raising like Sagimet Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.